APhA Statement Following Emergency Use Authorization of the Moderna COVID-19 Vaccine
CONTACT: Frank Fortin
WASHINGTON, DC -- Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists Association, upon the Food and Drug Administration’s (FDA) decision to authorize emergency use of Moderna’s COVID-19 vaccine:
“With the FDA’s action today, pharmacists are again prepared to step forward and serve as essential health care providers in the historic effort to control and end this pandemic.
“Throughout this past week, as the Pfizer-BioNTech vaccine found its way into institutions and communities across the country, trained and trusted pharmacists, student pharmacists and pharmacy technicians delivered the vaccine to thousands of front-line health care providers and residents of long-term care facilities. I expect the same to happen next week, when nearly 6 million doses are shipped to more than 3,000 locations across the country.
“We sincerely hope that the FDA’s actions over the past week mark the beginning of the end of the pandemic. We are confident in the care that the FDA has taken to ensure that the Moderna vaccine is safe and effective. Likewise, the American public should also have great confidence in the vaccine as an essential and effective component to the national effort, along with mask wearing and social distancing.”